Combining stem cells and genes for effective therapeutics.
作者信息
Ye Zhaoyang, Mahato Ram I
出版信息
Mol Pharm. 2011 Oct 3;8(5):1443-5. doi: 10.1021/mp200437m.
Abstract
摘要
相似文献
1
Combining stem cells and genes for effective therapeutics.将干细胞与基因相结合以实现有效的治疗。
Mol Pharm. 2011 Oct 3;8(5):1443-5. doi: 10.1021/mp200437m.
2
Progress and prospects: gene therapy clinical trials (part 2).进展与展望：基因治疗临床试验（第二部分）
Gene Ther. 2007 Nov;14(22):1555-63. doi: 10.1038/sj.gt.3303033.
3
Genetic modification of stem cells for improved therapy of the infarcted myocardium.干细胞的基因修饰用于改善梗死心肌的治疗。
Mol Pharm. 2011 Oct 3;8(5):1446-57. doi: 10.1021/mp2001318. Epub 2011 Jun 8.
4
Recent developments in gene transfer: risk and ethics.基因转移的最新进展：风险与伦理
BMJ. 2005 Jan 8;330(7482):79-82. doi: 10.1136/bmj.330.7482.79.
5
Five years of vector service for gene therapy.用于基因治疗的五年载体服务。
Trends Genet. 2002 Mar;18(3):118-9. doi: 10.1016/s0168-9525(01)02603-8.
6
Recent advances in the use of encapsulated cells for effective delivery of therapeutics.用于有效递送治疗药物的封装细胞应用的最新进展。
Ther Deliv. 2010 Sep;1(3):387-96. doi: 10.4155/tde.10.36.
7
Gene therapy revisited. In spite of problems and drawbacks, gene therapy moves forward.基因治疗再探讨。尽管存在问题和缺陷，但基因治疗仍在向前发展。
EMBO Rep. 2001 Dec;2(12):1064-5. doi: 10.1093/embo-reports/kve260.
8
Gene therapy as a novel pharmaceutical intervention for stroke.基因治疗作为一种新型药物干预手段治疗中风。
Curr Pharm Des. 2011;17(5):424-33. doi: 10.2174/138161211795164149.
9
Nanotechnology shaping stem cell therapy: Recent advances, application, challenges, and future outlook.纳米技术塑造干细胞治疗：最新进展、应用、挑战和未来展望。
Biomed Pharmacother. 2021 May;137:111236. doi: 10.1016/j.biopha.2021.111236. Epub 2021 Jan 21.
10
Genome medicine: gene therapy for the millennium.
Pharmacogenomics. 2002 Jan;3(1):15-8. doi: 10.1517/14622416.3.1.15.
本文引用的文献
1
Transplanted induced pluripotent stem cells improve cardiac function and induce neovascularization in the infarcted hearts of db/db mice.移植诱导多能干细胞可改善 db/db 小鼠梗死心脏的功能并诱导其新生血管形成。
Mol Pharm. 2011 Oct 3;8(5):1602-10. doi: 10.1021/mp2003576. Epub 2011 Sep 8.
2
Development of novel efficient SIN vectors with improved safety features for Wiskott-Aldrich syndrome stem cell based gene therapy.开发具有改进安全性特征的新型高效 SIN 载体，用于基于 Wiskott-Aldrich 综合征干细胞的基因治疗。
Mol Pharm. 2011 Oct 3;8(5):1525-37. doi: 10.1021/mp200132u. Epub 2011 Aug 31.
3
Gene-modified adult stem cells regenerate vertebral bone defect in a rat model.基因修饰的成体干细胞在大鼠模型中再生椎骨缺损。
Mol Pharm. 2011 Oct 3;8(5):1592-601. doi: 10.1021/mp200226c. Epub 2011 Sep 13.
4
Utilizing cell-matrix interactions to modulate gene transfer to stem cells inside hyaluronic acid hydrogels.利用细胞-基质相互作用来调节透明质酸水凝胶内干细胞的基因转移。
Mol Pharm. 2011 Oct 3;8(5):1582-91. doi: 10.1021/mp200171d. Epub 2011 Aug 24.
5
Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.肝细胞癌细胞及其纤维化微环境调节骨髓间充质基质细胞在体外和体内的迁移。
Mol Pharm. 2011 Oct 3;8(5):1538-48. doi: 10.1021/mp200137c. Epub 2011 Aug 19.
6
Glioma gene therapy using induced pluripotent stem cell derived neural stem cells.诱导多能干细胞衍生神经干细胞的脑胶质瘤基因治疗。
Mol Pharm. 2011 Oct 3;8(5):1515-24. doi: 10.1021/mp200127u. Epub 2011 Jul 22.
7
Stem cell based cancer gene therapy.基于干细胞的癌症基因治疗。
Mol Pharm. 2011 Oct 3;8(5):1480-7. doi: 10.1021/mp200151a. Epub 2011 Jul 25.
8
Hematopoietic stem cell gene therapy as a treatment for autoimmune diseases.造血干细胞基因治疗作为自身免疫性疾病的一种治疗方法。
Mol Pharm. 2011 Oct 3;8(5):1488-94. doi: 10.1021/mp2001523. Epub 2011 Jul 13.
9
A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.神经干细胞和间充质干细胞载体在恶性神经胶质瘤模型中用于溶瘤腺病毒的比较研究。
Mol Pharm. 2011 Oct 3;8(5):1559-72. doi: 10.1021/mp200161f. Epub 2011 Jun 30.
10
Genetically modified mesenchymal stem cells for improved islet transplantation.基因修饰间充质干细胞用于改善胰岛移植。
Mol Pharm. 2011 Oct 3;8(5):1458-70. doi: 10.1021/mp200135e. Epub 2011 Jul 7.
Zotero 插件